Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Atara Biotherapeutics Inc (ATRA)
Atara Biotherapeutics Inc (ATRA) News

ATRA

Atara Biotherapeutics (ATRA)

Atara Biotherapeutics Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ATRA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Date	Time	Source	Headline	Symbol	Company
01/26/2022	4:30PM	Business Wire	Atara Biotherapeutics Enters Strategic Manufacturing Partnership with Fujifilm	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/24/2022	1:25PM	TipRanks	Mizuho Securities Maintains a Buy Rating on Atara Biotherapeutics (ATRA)	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/24/2022	11:13AM	Business Wire	New Landmark Nature Study Provides Long-Sought Mechanistic Link Between EBV and Multiple Sclerosis, Extending Findings from Recent Paper in Science That Identified EBV as the Leading Cause of Multiple Sclerosis	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/12/2022	4:45PM	TipRanks	Atara Biotherapeutics (ATRA) Receives a Buy from Mizuho Securities	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/10/2022	9:37AM	Dow Jones News	Atara Biotherapeutics Sees Tabelecleucel FDA Meeting in 1Q	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/10/2022	8:35AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/10/2022	8:30AM	Business Wire	Atara Biotherapeutics to Present Recent Progress and Key Upcoming Catalysts at the 40th Annual J.P. Morgan Healthcare Conference	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/07/2022	4:01PM	Business Wire	Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/06/2022	10:00AM	Business Wire	Be The Match BioTherapies® and Atara Biotherapeutics Announce Multi-Year Partnership Extension	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/05/2022	4:48PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
01/05/2022	4:01PM	Business Wire	Atara Biotherapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference	NASDAQ:ATRA	Atara Biotherapeutics Inc
12/21/2021	5:14PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ATRA	Atara Biotherapeutics Inc
12/13/2021	7:15PM	Business Wire	Atara Biotherapeutics Announces Positive Results from Pivotal Phase 3 Trial (ALLELE) of Tab-cel® at the 63rd American Society of Hematology (ASH) Annual Meeting	NASDAQ:ATRA	Atara Biotherapeutics Inc
12/09/2021	8:00AM	Business Wire	Atara Biotherapeutics Announces Preliminary Results for ATA2271, a Next-Generation Autologous Mesothelin-targeted CAR T-cell Therapy for Solid Tumors, at ESMO Immuno-Oncology Congress 2021	NASDAQ:ATRA	Atara Biotherapeutics Inc
12/08/2021	11:39AM	TipRanks	William Blair Keeps a Buy Rating on Atara Biotherapeutics (ATRA)	NASDAQ:ATRA	Atara Biotherapeutics Inc
12/03/2021	4:16PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
12/03/2021	4:01PM	Business Wire	Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/30/2021	8:30AM	Business Wire	European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application for Tabelecleucel for the Treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/18/2021	5:55PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/18/2021	5:55PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/18/2021	5:54PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/18/2021	5:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/18/2021	5:53PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/08/2021	4:01PM	Business Wire	Atara Biotherapeutics to Participate at Three Upcoming Investor Conferences	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/05/2021	4:29PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/05/2021	4:01PM	Business Wire	Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/04/2021	4:11PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/04/2021	9:30AM	Business Wire	Atara Biotherapeutics to Present Eight Abstracts at the 63rd American Society of Hematology (ASH) Annual Meeting, Including First Presentation of Tab-cel® Pivotal Phase 3 (ALLELE) Data	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/04/2021	8:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ATRA	Atara Biotherapeutics Inc
11/04/2021	7:30AM	Business Wire	Atara Biotherapeutics Announces Third Quarter 2021 Financial Results and Operational Progress	NASDAQ:ATRA	Atara Biotherapeutics Inc

Showing the most relevant articles for your search:NASDAQ:ATRA

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 Next >>

Canopus Biopharma (PK)

Marketing Worldwide (PK)

Gold and GemStone Mining (PK)

Virexit Technologies (PK)

Bell Buckle (PK)

Seafarer Exploration (PK)

Fannie Mae (QB)

Ubiquitech Software (PK)

Brookmount Explorations (PK)

NioCorp Developments

Seven Arts Entertainment (PK)

Anavex Life Sciences

Decentral Life (PK)

Delayed Upgrade Clock